Fingerprint
Dive into the research topics of 'A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: A trial of the Eastern Cooperative Oncology Group (E1500)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically